Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Morpeth

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Sexually Transmitted Infections|February 11, 2011
High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal KenyaSarah Duncan, Alexander N Thiong'o, Michael Macharia, et al.
Plos One|August 9, 2017
Should first-line empiric treatment strategies cover coagulase-negative staphylococcal infections in severely malnourished or HIV-infected children in Kenya?Christina W Obiero, Anna C Seale, Kelsey Jones, et al.
BMC Infectious Diseases|June 25, 2010
High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western KenyaDaniel R Feikin, Geoffrey Jagero, Barrack Aura, et al.
The Pediatric Infectious Disease Journal|July 22, 2017
Should First-line Empiric Treatment Strategies for Neonates Cover Coagulase-negative Staphylococcal Infections in Kenya?Anna C Seale, Christina W Obiero, Kelsey D Jones, et al.
Trials|July 16, 2020
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trialJustin T Denholm, Joshua Davis, David Paterson, et al.
The New Zealand Medical Journal|November 23, 2020
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New ZealandShivani Fox-Lewis, Alana Whitcombe, Reuben McGregor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2026
Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trialDafna Yahav, Ruxandra Pinto, Deborah Cook, et al.
Trials|July 5, 2022
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Trials|June 27, 2022
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
The Pediatric Infectious Disease Journal|June 14, 2012
Treatment failure among Kenyan children with severe pneumonia--a cohort studyClare Webb, Mwanajuma Ngama, Anthony Ngatia, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Sexually Transmitted Infections|February 11, 2011
High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal KenyaSarah Duncan, Alexander N Thiong'o, Michael Macharia, et al.
Plos One|August 9, 2017
Should first-line empiric treatment strategies cover coagulase-negative staphylococcal infections in severely malnourished or HIV-infected children in Kenya?Christina W Obiero, Anna C Seale, Kelsey Jones, et al.
BMC Infectious Diseases|June 25, 2010
High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western KenyaDaniel R Feikin, Geoffrey Jagero, Barrack Aura, et al.
The Pediatric Infectious Disease Journal|July 22, 2017
Should First-line Empiric Treatment Strategies for Neonates Cover Coagulase-negative Staphylococcal Infections in Kenya?Anna C Seale, Christina W Obiero, Kelsey D Jones, et al.
Trials|July 16, 2020
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trialJustin T Denholm, Joshua Davis, David Paterson, et al.
The New Zealand Medical Journal|November 23, 2020
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New ZealandShivani Fox-Lewis, Alana Whitcombe, Reuben McGregor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2026
Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trialDafna Yahav, Ruxandra Pinto, Deborah Cook, et al.
Trials|July 5, 2022
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
Trials|June 27, 2022
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analysesPepa Bruce, Kate Ainscough, Lee Hatter, et al.
The Pediatric Infectious Disease Journal|June 14, 2012
Treatment failure among Kenyan children with severe pneumonia--a cohort studyClare Webb, Mwanajuma Ngama, Anthony Ngatia, et al.
Pageof 4